Pulvinar Neuro: Funding, Investors & Team (Aug 2026)
Pulvinar Neuro is to enable and support outstanding basic and translational neuroscience research through innovative and affordable products.
Pulvinar Neuro has raised $3.1M across 1 funding round on record, the most recent an undisclosed round of $3.1M announced in May 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pulvinar Neuro Company Profile and Key Stats
Latest funding round on record: May 2023.
Pulvinar Neuro Funding Rounds
Pulvinar Neuro Founders and Leadership Team
Contact details for the Pulvinar Neuro team: 1 of 1 has an email address on file.
Start 14-day free trial →Pulvinar Neuro Funding Compared to Other Biotechnology Startups
Pulvinar Neuro's latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pulvinar Neuro in Biotechnology and Durham
Companies Similar to Pulvinar Neuro
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Pulvinar Neuro Funding FAQs
What does Pulvinar Neuro do?
Pulvinar Neuro is to enable and support outstanding basic and translational neuroscience research through innovative and affordable products.
How much funding has Pulvinar Neuro raised?
Pulvinar Neuro has raised $3.1M across 1 round on record. The most recent is an undisclosed round of $3.1M announced in May 2023.
When did Pulvinar Neuro last raise funding?
Pulvinar Neuro's most recent funding round on record is an undisclosed round of $3.1M, announced in May 2023.
Who is the CEO of Pulvinar Neuro?
Leah Townsend is listed as CEO at Pulvinar Neuro.
Where is Pulvinar Neuro headquartered?
Pulvinar Neuro is based in Durham, North Carolina, United States.
How many employees does Pulvinar Neuro have?
Pulvinar Neuro is in the 1-10 employee band.
How does Pulvinar Neuro's funding compare to other Biotechnology startups?
Pulvinar Neuro's latest round of $3.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Pulvinar Neuro Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pulvinar Neuro is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.